A Prospective, Comparative Study of Intravenous Iron Isomaltoside 1000 (MonoferÂ®) Administered by Infusions to Non-Anaemic Patients Undergoing Elective or Sub-Acute Coronary Artery Bypass Graft, Valve Replacement or a Combination Thereof